<qa>  What is the primary objective of this study?This is a pilot study intended to provide the preliminary data for future clinical studies. Descriptive statistics will be used to characterize ETP and roTEG at initial presentation of sepsis. Means and ranges will be reported for each of the variables in the thrombin generation assay lag time, slope of rise, peak value, and area under the curve and roTEG Clot formation time CFT, maximum clot formation MCF, maximum velocity MaxVel of clot formation, time to maximum velocity T,MaxVel of clot formation, and area under the velocity curve AUC. The primary objective of this study is to compare ETP at presentation to the development of DIC, as defined by a positive ISTH DIC score. The secondary objective will be to compare host coagulation variables, including ETP, roTEG, Pro C, Pro S, ATIII, FVL, and prothrombin G20210A mutation at presentation, with the secondary outcome measures of 28-day mortality and organ dysfunction. All statistics will be performed using NCSSPASS. 